HFS
CYTK icon

Hughes Financial Services’s Cytokinetics CYTK Stock Holding History

Hughes Financial Services’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.9K Buy
34
+9
+36% +$646 ﹤0.01% 676
2026
Q1 		$1.65K Sell
25
-3
-11% -$191 ﹤0.01% 655
2025
Q4 		$1.78K Sell
28
-4
-13% -$249 ﹤0.01% 583
2025
Q3 		$1.99K Hold
32
– – ﹤0.01% 563
2025
Q2 		$1.12K Buy
32
+21
+191% +$730 ﹤0.01% 674
2025
Q1 		$413 Buy
+11
New +$506 ﹤0.01% 1004

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Hughes Financial Services's CYTK Position: Q2 2026 in Review

Hughes Financial Services increased its Cytokinetics (CYTK) stake by 36% in Q2 2026, buying an estimated $646 and bringing the position to 34 shares worth $2.9K. The position accounts for ﹤0.01% of the portfolio, ranked #676.

Hughes Financial Services first reported a position in CYTK in Q1 2025 and has held it in 6 quarters since. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Hughes Financial Services held 34 shares of Cytokinetics worth $2.9K as of Q2 2026.
  • Hughes Financial Services bought 9 Cytokinetics shares in Q2 2026, an estimated $646.
  • Cytokinetics made up ﹤0.01% of Hughes Financial Services's portfolio in Q2 2026, its #676 holding.
  • Hughes Financial Services first reported a position in Cytokinetics in Q1 2025 and has held it in 6 quarters since.
  • 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Hughes Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.